We developed surface modification tools for the fabrication of a bioelectronic device which consists of a myoglobin monolayer self-assembled on an 11-MUA layer. To utilize a single protein as the active element, it was necessary to reduce protein aggregation on the protein layer in the nanobio electronic device, which was developed in our previous study and shown to display basic biomemory functions. Here, the reduction of myoglobin aggregation was accomplished by using 3-(3-cholamidopropyl) dimethylammonio-1-propanesulfonate (CHAPS) to fabricate a well-defined protein layer on the bioelectronic device. We investigated two different surface modification methods for making well oriented biofilm. The effects of CHAPS on the formation of a myoglobin layer selfassembled on an 11-MUA layer were examined by atomic force microscopy and Raman spectroscopy. The size of the myoglobin aggregates was reduced from 200∼250 nm to 10∼40 nm depending on treatment method. The sustaining redox property of the CHAPS treated myoglobin layer was examined using cyclic voltammetry. Using these techniques, we found that after surfactant CHAPS treatment, protein aggregation was dramatically reduced and the protein layer still maintained its inherent electrochemical properties.
INTRODUCTION
Recently, the semiconductor industry has been confronted with serious economical and technological problems. Particularly, it has been technologically difficult to produce a line width that is under the 50 nm regime and semiconductor products have generally been of low yield. Also, the fabricating and manufacturing costs have increased in direct proportion to the technological degree of difficulty when the current 'top-down' method is used. These problems have hampered the development of new advanced semiconductor devices by the semiconductor industry. [1] [2] [3] [4] There have been intensive efforts by several scientists and engineers to resolve these problems. As a result, a molecular electronic device has been suggested as * Author to whom correspondence should be addressed. a potential powerful alternative solution to the current problems facing the semiconductor industry. Molecular electronics are based on a different type of technology than what is currently being used by the semiconductor industry. The 'bottom-up' method to fabricate functional structures with molecules can be potentially used to fabricate nano electronic devices that are under the 100 nm regime. Using this concept, many molecular electronic devices on the nanoscale have been devised and applied as electronic devices, such as the sensor, diode and the other electronic devices consisting of various chemical and bio materials. [5] [6] [7] [8] [9] We have previously proposed a shift register memory composed of a Langmuir-Blodgett (LB) film to fabricate a molecular scale diode, biomolecule-based rectifier for photocurrent generation. Recently, a molecular electronic device based on biomolecule was suggested. By using a biomolecule-based bioelectronic device, the charge (information) could be stored in and read out using an external potential that one can control. [10] [11] [12] [13] [14] [15] However, this biomemory device has faced some problems regarding biomolecule control, which needs to be resolved before this concept can be used for the development of a nano-scaled bioelectronic device. When metalloproteins are immobilized on Au surface, they tend to aggregate with each other. As a result, the proteins in the proteinimmobilized layer are not well orientated on the surface. In this study, surfactant treatment was used with the aim of creating a well oriented metalloprotein layer.
Myoglobin is a 17.3 kDa protein that consists of 153 amino acids. Myoglobin has one heme prosthetic group containing an iron ion. This iron ion is responsible for electron transfer by switching from a ferrous state to a ferric state or rather switching from an oxidation state to a reduction state. This redox property is easily and efficiently utilized for the transfer of materials such as oxygen in biological systems. When the two different forms of myoglobin are switched on a substrate using an external potential, the change in the redox state can be easily monitored using reliable tools. These simple electrochemical properties of myoglobin can thus be exploited for the development of a bioelectronic device that has memory functions. In the present study, a 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) was used to control the surface orientation for additional treatment to make the well-ordered bioelectronic device. As a surfactant, CHAPS was well known for segregating the protein clusters and this surfactant used for control the micellization and adsorption the protein aggregates. 16 17 Therefore, the purpose of this study was, first, to form a well defined myoglobin layer, which does not contain large aggregates. Second, to retain its redox property which display well when treated by CHAPS. Here, we are trying to find out an optimal surface modification method to apply the molecular electronic device which contains the biomolecules. We investigated the two different surface modification methods.
Successful immobilization of myoglobin on the Au substrate via 11-MUA layer and CHAPS were confirmed by surface resonance spectroscopy (SPR) and atomic force microscopy (AFM). Also, a Raman spectroscopy was carried out for confirming the surface compositions. The redox property of the myoglobin layer with CHAPS treatment was assessed by cyclic voltammetry (CV). A schematic diagram shows the CHAPS treatment which was used to physically reduce protein aggregation. Figure 1(a) shows the myoglobin mixed with CHAPS solution, and then immobilized on 11-MUA modified Au substrate. Figure 1(b) describes the effects of CHAPS treatment on the myoglobin layer self-assembled on the gold substrate via an 11-MUA layer.
EXPERIMENTAL DETAILS

Materials
Au substrates prepared by e-beam evaporation of 400 nm of gold onto the clean and polished (100) plane of a p-type silicon single crystal wafer primed with an adhesion layer of about 10 nm of Cr, were purchased from G-mek (Korea Au substrates were cleaned by immersing into piranha solution with a 3:1 (v/v) mixture of sulfuric acid and hydrogen peroxide for 5 min at 65 C to remove organic residues and dusts on the surface. The substrates were then rinsed with deionized water and dried under a stream of N 2 gas. After washing, the surface of the substrates were modified with 11-MUA. 150 mM 11-MUA solution was dissolved in 5:5 (v/v) ethanol and glycerol. The substrate was dipped into the 11-MUA solution for twelve hours. During this incubation period, the thiol groups on the 11-MUA molecules were covalently attached to the Au molecules on the Au surface. The carboxyl groups on the terminal ends of the 11-MUA molecules were used to bind to the external amine groups of myoglobin through electrostatic interactions. After this step, the modified substrate was rinsed with ethanol and DI water to eliminate excess alkanethiols that bound to the surface through physical adsorption. Finally, the 11-MUA modified Au surface was immersed in 0.1 mg/ml myoglobin solution dissolved in the 10 mm HEPES buffer solution for 6 hrs. 19 
Segregation of Myoglobin Aggregates by Surfactant CHAPS
The two methods were carried out to determine the optimal treatment method. At first treatment method, the mixed solution was shaked with a shaker set at 200 rpm for 24 hrs at 4 C. And then, the mixed myoglobin was purified 3000 MWCO Amicon filter (Millipore, USA) for eliminating the excess CHAPS molecules. And then, the mixed myoglobin solution was dropped onto the 11-MUAmodified Au surface for self-assembly processing. After this step, the surfactant-modified substrate was washed with DI water. The surface-modified substrates were dried under a stream of N 2 gas. Second treatment method, the myoglobin of 0.1 mg/ml solution was diluted in 10 mM CHAPS solution for isolating the aggregation. The prepared Au substrates were immersed in a 10 mM CHAPS solution to stir the treated solution. The substrates were stirred in a shaker set at 200 rpm for 24 hrs at 4 C to eliminate physically adsorbed excess myoglobin-CHAPS clusters. After this step, the surfactant-modified substrate was washed with DI water. The surface-modified substrates were dried under a stream of N 2 gas.
Confirmation of Surface-Modified
Myoglobin/11-MUA by Surface Plasmon Resonance (SPR)
The surface plasmon resonance (SPR) spectroscopy (Multiskop™, Germany) equipped with He-Ne laser as a light source (wavelength: 632.8 nm) was operated for confirming the myoglobin/11-MUA heterolayer fabrication. The angle position was affected by the thickness of the fabricated structure on the Au substrate. When the angle shift was changed from 38 to 50 , the data was monitored and acquired. A plane face of the glass prism (BK7, n = 1 5168) was faced with the Au coated glass via matching oil, and it was used to a Kretchmann's ATR coupler for experiment. Free electrons from the fabricated surface were flowed by the external laser area. A change from the localized electron distribution made a localized electric field between metal and dielectric interface. The SPR experiments were carried out at room temperature. 19 
Analysis of Myoglobin Layer Immobilized on 11-MUA by Raman Spectroscopy
Raman spectroscopy was performed using a NTE-GRA Spectra (Scanning Confocal Raman Spectrometer, NTMDT, Russia) equipped with an inverted optical microscope (Olympus IX71) and a liquid nitrogen-cooled CCD detector. The XYZ scanning range was 100 m × 100 m × 6 m. Raman spectra were monitored using an infrared laser that emitted light at a 785 nm wavelength. Twelve scans of 60 s from 500-1600 cm −1 were obtained and the mean intensity was used as the Raman signals.
Topographic Analysis of Myoglobin Layer by Atomic Force Microscopy (AFM)
The surface morphology of the substrates was investigated by AFM (Digital instruments Nanoscope (R) IV, USA). AFM was used to investigate the topography of the surface after protein immobilization with and without surfactant CHAPS treatment. AFM images were acquired in tapping mode using 1-10 -cm Phosphorous (n) doped (Si) tips, which has a resonant frequencies between 230-305 kHz. The scanning size was 400 nm × 400 nm and a scan rate of 1.5 Hz was used.
Electrochemical Analysis of Myoglobin Layer
The electrochemical analysis was performed with a CHI660A electrochemical workstation (CH Instruments, USA) and a standard three-electrode system. The myoglobin layer self-assembled on the 11-MUA layer was used as the working electrode. The platinum wire (Bas, USA) and standard Ag/AgCl electrodes (Bas, USA) were used as the counter electrode and reference electrode, respectively. All electrochemical experiments were carried out in the HEPES buffer solution, which was used as the electrolyte. Previous study, we determined that the optimal concentration of metalloprotein for maximal immobilization was 0.100 mg/ml. 13 As a result, all measurements were conducted based on optimized protein concentration. SPR experiments were carried out bare gold surfaces, 11-MUA immobilized onto gold surfaces and myoglobin selfassembled on 11-MUA modified gold substrates. Also, myoglobin mixed with 10 mM CHAPS solution was immobilized on 11-MUA self-assembled Au surface to determine the effect of surface modification method as a first treatment method by SPR. Moreover, after CHAPS treatment by stirring solution, the angle shift of myoglobin/11-MUA modified substrate was investigated by SPR.
RESULTS AND DISCUSSION
The SPR angle shifts were compared to understand the immobilization process and the effect of modification method by CHAPS in Figures 2(a) and (b). After 11-MUA self-assembled on the Au surface, an angle shift from 43 000 ± 0 008" to 43 093 ± 0 039" was monitored. Furthermore, after myoglobin was immobilized onto the 11-MUA modified surface, the angle shift from 43 000 ± 0 016" to 43 461 ± 0 051" revealed. This result implies myoglobin layer was well adsorbed onto the inorganic surface via a chemical linker. Also, there was a significant angle shift after CHAPS treatment. In case of myoglobin diluted with CHAPS solution, the angle shift was drastically decreased from 43 461 ± 0 051" to 43 287 ± 0 042". This result means that myoglobin which was bound physically was segregated by surfactant CHAPS. So, thickness of myoglobin layer reduced compared to myoglobin without CHAPS treatment. Moreover, in case of myoglobin/11-MUA layer after CHAPS treatment by stirring, the angle shift was decremented from 43 461 ± 0 051" to 43 410 ± 0 014". Figure 2 (b) displays the total angle shifts of these results. Presumably, in case of myoglobin mixed with CHAPS, this large angle decrement was due to elimination of myoglobin aggregates. But, the CHAPS molecule hampered the self-assembly process between myoglobin and 11-MUA. So, the myoglobin layer couldn't form well. When CHAPS treatment was stirred after myoglobin/11-MUA formed, the angle shift was slightly reduced compared to first treatment method, however, this treatment didn't inhibit the immobilization process because CHAPS molecule bound after myoglobin immobilization was finished. Based on these combined results, it was concluded that CHAPS treatment was efficiently reduced the protein aggregates.
Investigation of the Surface-Modified
Myoglobin Layer Self-Assembled on 11-MUA Layer Using Raman Spectroscopy and C-H deformation (1432 cm −1 . This spectrum is similar to the reported raman spectra of 11-MUA molecules. 20 In agreement with previous reports, 21 22 the intense peaks in the Raman spectra of myoglobin ( Fig. 3(b) approximately 1440 cm −1 and Amide III near 1550 cm −1 . Interestingly, the Raman spectrum of myoglobin after treatment with CHAPS ( Fig. 3(c) ) was different from the spectrum of control Myoglobin under identical conditions, suggesting that some perturbation in the solubility, coordination geometry, electronic structure, or all of these factors occurred during CHAPS treatment. 23 24 
The Morphology Analysis of Myoglobin Layer by Atomic Force Microscopy (AFM)
The surface morphology of the surface-modified myoglobin layer and myoglobin without any treatment immobilized was investigated using AFM. Figure 4(a) shows an AFM image of the myoglobin self-assembled on the 11-MUA layer. The AFM image of the surfactant CHAPS treated myoglobin layer was shown in Figure 4(b) . As shown in Figure 3(a) , the cluster size of myoglobin displays when the surface was not treated with CHAPS, indicating that the myoglobin layer was not well oriented on the surface. However, when myoglobin mixed with CHAPS, the myoglobin didn't well immobilize on 11-MUA layer. Figure 4(b) describes an AFM image of the myoglobin layer mixed with surfactant CHAPS. The cluster sizes of myoglobin were roughly 5 nm to 15 nm. In this case, the myoglobin layer didn't immobilized well. Presumably, the some CHAPS molecules bound with hydrophilic part of myoglobin molecule. 17 When surfactant CHAPS treatment after myoglobin immobilized was performed, the myoglobin layer was well oriented and its cluster sizes were roughly between 30 nm to 50 nm. These results indicate that physically absorbed proteins were successfully removed after treatment of the myoglobin immobilized 11-MUA layer with CHAPS. With these results, the surfactant CHAPS affects the surface morphology and aggregation of myoglobin layer.
The Speculation of Electrochemical Property
Using Cyclic Voltammetry (CV)
The cyclic voltammogram was used to measure the electrochemical properties of the myoglobin layer immobilized on the Au electrode with and without CHAPS treatment. When CHAPS treatment was not used, reversible oxidation and reduction peaks of the myoglobin were observed in the voltammogram, as shown in Figure 5 (a). Based on our previous work, 13 0.10 mg/ml of protein was immobilized on the 11-MUA/gold substrate and the voltammetric experiment was carried out using 10 mM HEPES buffer as the electrolyte. In addition, a scan range from 600 mV to −100 mV was used with a 50 mV/s scan rate.
When the surface was not subjected to CHAPS treatment, the oxidation and reduction potential of the myoglobin layer were 462 mV and 213 mV, respectively ( Fig. 5(a) ). In case of myoglobin mixed with CHAPS treatment, the redox potential was drastically attenuated compared to previous case. The oxidation potential was 119 mV and reduction potential was 302 mV respectively. Figure 5 (b) depicted the decreased redox potential. Presumably, this phenomenon was originated from the too many CHAPS molecules bound to the hydrophilic patch of myoglobin region. So, the myoglobin can't possible to immobilize to the carboxyl group of 11-MUA owing to presence of CHAPS. As a result, the treatment method of myoglobin mixed with CHAPS was not suitable to modification-method for making well ordered and well oriented nanoscale biofilm. So, we finally determined that optimal modification method is immobilized onto the myoglobin/11-MUA after CHAPS treatment. When CHAPS treatment by stirred with shaker was used, the oxidation and reduction potential of the myoglobin layer were 231 mV and 478 mV, respectively (Fig. 5(c) ).
A comparison of the these oxidation and reduction potentials clearly indicate that there were some differences regarding the redox properties of the myoglobin layer due to the elimination of the physically adsorbed myoglobin clusters. After CHAPS treatment, the redox potential was reduced, but still maintained its original characteristics. The stable potentials observed from the cyclic voltammogram show that the proteins were efficiently immobilized onto the 11-MUA/gold surface after CHAPS treatment. Thus, the use of surfactant treatment during protein immobilization prevents the physical adsorption of proteins to the protein layer. With these results, the stable electrical properties of myoglobin on the 11-MUA layer after CHAPS treatment imply that surfactant treatment can produce very stable and well oriented protein layers for bioelectronic device application.
The Determination of the Treatment Method
The surface morphology of the surfactant-treated surface was investigated by AFM to determine the CHAPS effect in previous session. In this session, we compared the characteristics dependence on different CHAPS treatment and Figure 6 (a) shows the graph considering size distribution about these treatment results and Figure 6( of myoglobin did not sustain its original characteristics. As a result, we finally concluded that the desirable method is the treatment of self-assembled on myoglobin via 11-MUA layer stirred in 10 mM CHAPS solution. With this method, we can possible to make a well ordered and oriented protein film for making a bioelectronic device.
CONCLUSION
In this study, a surface-modified methodology was developed using the surfactant CHAPS to remove protein aggregates for bioelectronic device. To assess the effect of CHAPS treatment, the surface topology was examined by AFM. As a result, CHAPS treatment was shown to reduce protein aggregation on the surface. The composition of the fabricated surface was analyzed by Raman spectroscopy to confirm the successful fabrication of the layer of myoglobin self-assembled on the 11-MUA layer. The surfacemodified myoglobin layer maintained its stable redox properties by CV. With these results, it was shown that the surfactant CHAPS did not alter the redox properties of the immobilized myoglobin layer. These results also proved that the surface-modified bioelectronic device was robust and well orientation. This surface-modified myoglobin film holds promise for use as a novel nanobiochip that displays an intrinsic switch function.
